These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 6446390)
1. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates. Trabulsi LR; Pereira da Silva Almada N; Marques LR Clin Ther; 1980; 3(Spec Issue):145-8. PubMed ID: 6446390 [No Abstract] [Full Text] [Related]
2. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine. Piantieri G; Cafarelli A; Magliulo E G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524 [No Abstract] [Full Text] [Related]
3. Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains. Dainelli B; Magni A; Maragoni F; Berlutti F; Thaller MC; Filadoro F G Batteriol Virol Immunol; 1981; 74(1-6):8-14. PubMed ID: 6458528 [No Abstract] [Full Text] [Related]
4. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae. Phillips I; Shannon K Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833 [TBL] [Abstract][Full Text] [Related]
5. Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli. Farrar WE; O'Dell NM Infection; 1977; 5(4):224-7. PubMed ID: 413793 [TBL] [Abstract][Full Text] [Related]
6. In vitro bactericidal action of cephalosporins in different concentrations of serum. Magliulo E; Ceccarelli G; Bianchi PP; Piantieri G; Cafarelli A G Batteriol Virol Immunol; 1981; 74(1-6):39-47. PubMed ID: 6458527 [No Abstract] [Full Text] [Related]
7. The in vitro spectrum of the cephalosporins. Washington JA Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595 [TBL] [Abstract][Full Text] [Related]
8. Effects of the variations in inoculum on the cephalosporins' in vitro antibacterial activity. Cafarelli A; Magliulo E; Piantieri G G Batteriol Virol Immunol; 1981; 74(1-6):26-38. PubMed ID: 6458525 [No Abstract] [Full Text] [Related]
9. In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin. Brenciaglia MI; Cipriani P; Ghezzi MC; Giordano A; Mancini C; Rivanera D; Filadoro F Chemioterapia; 1984 Aug; 3(4):246-9. PubMed ID: 6099754 [TBL] [Abstract][Full Text] [Related]
10. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins]. Torres A; Aguirre M; Ales JM Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674 [No Abstract] [Full Text] [Related]
11. In vitro activity of cefoperazone against clinical isolates of Enterobacteriaceae, Pseudomonas and Staphylococcus. Olarte J Clin Ther; 1980; 3(Spec Issue):130-3. PubMed ID: 6446386 [No Abstract] [Full Text] [Related]
12. [In vitro sensitivity of hospital-isolated pathogenic bacterial strains to 4 different cephalosporins: cephaloridine, cefotaxime, cefoxitin, cefonicid]. Rosina M; Mauri J; Germiniani R; Mastropasqua E; Figini G Minerva Chir; 1986 Aug; 41(15-16):1347-51. PubMed ID: 3774182 [No Abstract] [Full Text] [Related]
13. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin. Rosenthal SL; Freundlich LF; Quraishi MA Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076 [TBL] [Abstract][Full Text] [Related]
14. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime. Harper PB Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates. Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389 [No Abstract] [Full Text] [Related]
16. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins]. Braveny I; Dickert H; Machka K Infection; 1979; 7(5):231-6. PubMed ID: 389804 [TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae. Ott JL; Turner JR; Mahoney DF Antimicrob Agents Chemother; 1979 Jan; 15(1):14-9. PubMed ID: 311615 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of aerobic and anaerobic Gram-negative rods to cefoxitin and related compounds. Yeivin R; Peretz J; Sacks T Isr J Med Sci; 1979 Oct; 15(10):856-8. PubMed ID: 521267 [No Abstract] [Full Text] [Related]
19. The cephalosporins: activity and clinical use. Weinstein AJ Drugs; 1980 Aug; 20(2):137-54. PubMed ID: 6995096 [TBL] [Abstract][Full Text] [Related]
20. [Clinico-microbiologic bases for the use of new cephalosporins]. De Bac C; Mascellino MT; Nuti M Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006 [No Abstract] [Full Text] [Related] [Next] [New Search]